Estimating success of vaginal birth after caesarean section in a regional Australian population: Validation of a prediction model.


Journal

The Australian & New Zealand journal of obstetrics & gynaecology
ISSN: 1479-828X
Titre abrégé: Aust N Z J Obstet Gynaecol
Pays: Australia
ID NLM: 0001027

Informations de publication

Date de publication:
02 2019
Historique:
received: 08 05 2017
accepted: 28 02 2018
pubmed: 20 4 2018
medline: 17 4 2020
entrez: 20 4 2018
Statut: ppublish

Résumé

Following a primary caesarean section (CS), women must decide between attempted vaginal birth after caesarean (VBAC) and elective repeat caesarean section (ERCS) in subsequent pregnancies. Both options carry potential morbidity and mortality for mother and child, with the most feared being uterine rupture and its consequences. In attempts to reduce morbidity, several predictive nomograms have been developed to assist in delivery mode decisions. To assess the validity of the predictive nomogram developed by Grobman et al. in our regional Australian population. In our retrospective analysis, patients at term, with one previous CS who had a trial of labour were assigned a 'Grobman score' based on antenatal details. Outcomes were noted and patient groups analysed according to percentage deciles of estimated VBAC success, compared with actual VBAC success rates. A total of 395 women underwent trial of labour after a single prior CS, with a VBAC success rate of 83%. The Grobman model displayed adequate calibration and the re-calibrated model good calibration with the slope coefficient of 0.87 (95% CI 0.54-1.19) and intercept 0.19 (95% CI -0.34-0.72). Discrimination was moderate with receiver operating characteristic area of 0.71 (95% CI 0.67-0.76). This analysis supports further validation studies in larger Australian settings, and suggests that use of the original Grobman predictive nomogram may be appropriate in Australia.

Sections du résumé

BACKGROUND
Following a primary caesarean section (CS), women must decide between attempted vaginal birth after caesarean (VBAC) and elective repeat caesarean section (ERCS) in subsequent pregnancies. Both options carry potential morbidity and mortality for mother and child, with the most feared being uterine rupture and its consequences. In attempts to reduce morbidity, several predictive nomograms have been developed to assist in delivery mode decisions.
AIM
To assess the validity of the predictive nomogram developed by Grobman et al. in our regional Australian population.
MATERIALS AND METHODS
In our retrospective analysis, patients at term, with one previous CS who had a trial of labour were assigned a 'Grobman score' based on antenatal details. Outcomes were noted and patient groups analysed according to percentage deciles of estimated VBAC success, compared with actual VBAC success rates.
RESULTS
A total of 395 women underwent trial of labour after a single prior CS, with a VBAC success rate of 83%. The Grobman model displayed adequate calibration and the re-calibrated model good calibration with the slope coefficient of 0.87 (95% CI 0.54-1.19) and intercept 0.19 (95% CI -0.34-0.72). Discrimination was moderate with receiver operating characteristic area of 0.71 (95% CI 0.67-0.76).
CONCLUSION
This analysis supports further validation studies in larger Australian settings, and suggests that use of the original Grobman predictive nomogram may be appropriate in Australia.

Identifiants

pubmed: 29672825
doi: 10.1111/ajo.12809
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

66-70

Informations de copyright

© 2018 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Auteurs

Samantha S Mooney (SS)

Obstetrics & Gynaecology Department, Albury-Wodonga Health, Wodonga, Victoria, Australia.
Obstetrics & Gynaecology Department, Mercy Hospital for Women, Melbourne, Victoria, Australia.

Richard Hiscock (R)

Department of Anaesthetics, Mercy Hospital for Women, Melbourne, Victoria, Australia.

Inkeri D'Arcy Clarke (ID)

Albury-Wodonga Rural Clinical School (UNSW), Albury, New South Wales, Australia.

Simon Craig (S)

Obstetrics & Gynaecology Department, Albury-Wodonga Health, Wodonga, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH